Predictors of long-term drug survival for infliximab in psoriasis

被引：0
|
作者：
Magis, Q. [1 ]
Jullien, D. [2 ]
Gaudy, C. [1 ]
Baumstark, K. [3 ]
Viguier, M. [4 ]
Bachelez, H. [5 ]
Guibal, F. [6 ]
Delaporte, E. [7 ]
Karimova, E. [7 ]
Montaudie, H. [8 ]
Boye, T. [9 ]
Aubin, F. [10 ]
Beylot-Barry, M. [11 ]
Richard, M. -A. [1 ]
机构：
[1] Hop La Timone, Dermatol, Marseille, France
[2] Hop Edouard Herriot, Lyon, France
[3] Aix Marseille Univ, Clin Res, Marseille, France
[4] Hop La Sorbonne, Dermatol, Paris, France
[5] Hop St Louis, Paris, France
[6] Hop St Louis, Dermatol, Paris, France
[7] Reg Univ Hosp, Lille, France
[8] Hop LArchet, Nice, France
[9] Hop Instruct Armees St Anne, Dermatol, Toulon, France
[10] Hop Jean Minjoz, Dermatoloie, Besancon, France
[11] Hop St Andre, Dermatol, Bordeaux, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2016年 / 30卷
关键词：
infliximab; long-term drug survival; predictors of long term survival;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P192
引用
收藏
页码：96 / 97
页数：2
相关论文
共 50 条
  • [31] Independent Predictors of Long-term Survival in Acute Pancreatitis
    Skouras, C.
    Williams, L.
    Garden, O. J.
    Parks, R. W.
    Mole, D. J.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 56 - 57
  • [32] Predictors of long-term survival in nonagenarians: the NonaSantfeliu study
    Formiga, Francesc
    Ferrer, Assumpta
    Chivite, David
    Rubio-Rivas, Manuel
    Cuerpo, Sandra
    Pujol, Ramon
    AGE AND AGEING, 2011, 40 (01) : 111 - 116
  • [33] Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long-term experience
    Galache-Osuna, Cristina
    Reyes-Garcia, Sebastian
    Salgueiro, Esther
    Bordallo-Landa, Javier
    Lozano, Ana
    Vazquez-Lopez, Francisco
    Santos-Juanes, Jorge
    DERMATOLOGIC THERAPY, 2022, 35 (07)
  • [34] Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study
    Ring, Hans Christian
    Thorsen, Jonathan
    Kirby, Brian
    Ingram, John R.
    Roseno, Nana Aviaaja Lippert
    Holgersen, Nikolaj
    Nielsen, Valdemar W.
    Aagaard, David Nikolai Thein
    Maul, Julia-Tatjana
    Wu, Jashin J.
    Thyssen, Jacob P.
    Egeberg, Alexander
    Thomsen, Simon F.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 (05) : 769 - 771
  • [35] Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naive Patients with Ulcerative Colitis
    Dalal, Rahul S.
    McClure, Emma L.
    Marcus, Jenna
    Allegretti, Jessica R.
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (01) : 223 - 232
  • [36] Long-term Safety Monitoring and Efficacy Status of Infliximab and its Biosimilars in Psoriasis Management
    Sharma, Kiran
    Ghai, Roma
    Rana, Neha
    CURRENT DRUG SAFETY, 2024,
  • [37] Long-term efficacy and safety of infliximab in the treatment of patients affected by psoriasis and psoriatic arthritis
    Papoutsaki, M.
    Talamonti, M.
    Giunta, A.
    Costanzo, A.
    Chimenti, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 : 47 - 48
  • [38] Long-term treatment of 4.5 years with infliximab: A case report of a patient with severe psoriasis
    Vussuki, Eyal
    David, Michael
    Bank, Ilan
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1822 - 1822
  • [39] Generalized dermatophytosis and tinea capitis mimicking psoriasis in a patient with long-term infliximab treatment
    Balaguer-Franch, I.
    Hernandez de la Torre-Ruiz, E.
    Baniandres-Rodriguez, O.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (04) : 750 - 751
  • [40] Long-term treatment of 4 years with infliximab: A case report of a patient with severe psoriasis
    Vussuki, Eyal
    David, Michael
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 (07) : 1813 - 1813
12345